Literature DB >> 1961437

Prolonged postpartum urinary retention.

W J Watson1.   

Abstract

Urinary retention after vaginal delivery is a relatively common problem, usually resolved by the temporary use of an indwelling catheter. Presented are two patients with persistent bladder atony after vaginal delivery, despite the use of an indwelling catheter for 10 days. Both patients had low forceps deliveries without severe perineal trauma. Both were treated by self-intermittent catheterization, with resolution of urinary retention at 24 and 37 days postpartum, respectively. These patients were able to learn this technique with minimal instruction. Advantages of intermittent catheterization over prolonged use of an indwelling catheter include greater patient acceptance and possible reduction in the incidence of urinary tract infection.

Entities:  

Mesh:

Year:  1991        PMID: 1961437

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  4 in total

1.  Incidence and treatment of urinary retention postpartum.

Authors:  Karin Glavind; Jonna Bjørk
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-03-12

Review 2.  Postpartum urinary retention: a systematic review of adverse effects and management.

Authors:  F E M Mulder; R A Hakvoort; M A Schoffelmeer; J Limpens; J A M Van der Post; J P W R Roovers
Journal:  Int Urogynecol J       Date:  2014-05-20       Impact factor: 2.894

3.  Prospective 3D ultrasonographic evaluation of immediate postpartum urine retention volume in 100 women who delivered vaginally.

Authors:  F Demaria; N Amar; D Biau; X Fritel; R Porcher; G Amarenco; P Madelenat; J L Benifla
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004 Jul-Aug

4.  Delivery-related risk factors for covert postpartum urinary retention after vaginal delivery.

Authors:  Femke E M Mulder; Katrien Oude Rengerink; Joris A M van der Post; Robert A Hakvoort; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2015-07-30       Impact factor: 2.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.